1. Caspofungin vs amphotericin B deoxycholate in the treatment of invasive candidiasis in neutropenic and non-neutropenic patients: a multi-centre, randomized, double-blind study;Mora-Duarte;N Engl J Med,2002
2. Reboli A, Rotstein C, Pappas P, Schranz J, Krause D, Walsh T: Abstract M-718: Anidulafungin vs fluconazole for treatment of candidemia and invasive candidiasis. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, December 16–19, 2005.
3. Ruhnke M, Kuse ER, Chetchotisakd P, Arns Da Cunha C, Diekmann-Berndt H: Abstract M-722c: Comparison of micafungin and liposomal amphotericin B for invasive candidiasis. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington DC, December 16–19, 2005.
4. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis;Moudgal;Antimicrob Agents Chemother,2005
5. Caspofungin resistance in Candida albicans: Correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis;Hernandez;Antimicrob Agents Chemother,2004